Barclays Lowers Estimates on Heartware Int'l (HTWR); Q1 and 10-Q Review
Tweet
Share
E-mailGet Alerts HTWR Hot Sheet
Price: $57.98 --0%
Rating Summary:
5 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Heartware Int'l (NASDAQ: HTWR) price target of $90.00.
Analyst, Matthew Taylor, said, "HTWR released solid 1Q results last week marked by operational strength in Europe, international center adds, the recent completion of ENDURANCE enrollment, and a positive FDA panel recommendation. Following the successful panel, HTWR is turning its focus to labeling and post-approval studies, and is actively involved in discussions with the FDA."
As far as the issues in HTWR's 10-Q, Taylor said there were no new material disclosures relating to warning letters, subpoenas, litigation, recalls, or gov't investigations. However, Taylor did cut FY12 loss from -3.54 to -4.53 and FY13 from -1.05 to -1.38.
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $80.99 yesterday.
Analyst, Matthew Taylor, said, "HTWR released solid 1Q results last week marked by operational strength in Europe, international center adds, the recent completion of ENDURANCE enrollment, and a positive FDA panel recommendation. Following the successful panel, HTWR is turning its focus to labeling and post-approval studies, and is actively involved in discussions with the FDA."
As far as the issues in HTWR's 10-Q, Taylor said there were no new material disclosures relating to warning letters, subpoenas, litigation, recalls, or gov't investigations. However, Taylor did cut FY12 loss from -3.54 to -4.53 and FY13 from -1.05 to -1.38.
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $80.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
